HF
SLDB icon

HRT Financial’s Solid Biosciences SLDB Stock Holding History

HRT Financial’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-86,905
Closed -$625K – 5238
2026
Q1 		$625K Buy
86,905
+71,986
+483% +$463K ﹤0.01% 2355
2025
Q4 		$84K Sell
14,919
-141,903
-90% -$769K ﹤0.01% 2808
2025
Q3 		$967K Buy
+156,822
New +$917K ﹤0.01% 1534
2025
Q2 		– Sell
-15,051
Closed -$55K – 3441
2025
Q1 		$55K Buy
+15,051
New +$64.4K ﹤0.01% 2232
2021
Q2 		– Sell
-864
Closed -$71K – 3464
2021
Q1 		$71K Buy
+864
New +$95.6K ﹤0.01% 2499

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's SLDB Position: Q2 2026 in Review

HRT Financial sold out of Solid Biosciences (SLDB) in Q2 2026, closing a stake of 86,905 shares — an estimated $625K sold.

HRT Financial first reported a position in SLDB in Q1 2021 and held it in 5 quarters. The position peaked at $967K in Q3 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • HRT Financial reported no remaining Solid Biosciences position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 86,905 Solid Biosciences shares in Q2 2026, an estimated $625K.
  • HRT Financial first reported a position in Solid Biosciences in Q1 2021 and held it in 5 quarters.
  • HRT Financial's Solid Biosciences position peaked at $967K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.